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CASE

SERIES

Severe acute generalized exanthematous
pustulosis with toxic epidermal necrolysislike desquamation: A case series of 8 patients
Simo Huang, MD,a Amara Ahmed, BS,b Sylvia Hsu, MD,a Jason Lee, MD,c and Kiran Motaparthi, MDd
Philadelphia, Pennsylvania and Tallahassee and Gainesville, Florida
Key words: acute generalized exanthematous pustulosis; AGEP; case series; SCAR; severe cutaneous adverse
drug reaction; SJS; Stevens-Johnson syndrome; TEN; toxic epidermal necrolysis.

INTRODUCTION
Acute generalized exanthematous pustulosis
(AGEP) is a severe cutaneous adverse reaction
(SCAR) with heterogeneous clinical and histopathologic features. Notably, extensive cases of AGEP can show
overlapping features with toxic epidermal necrolysis
(TEN) by presenting with widespread desquamation
and necrotic keratinocytes on histopathology. AGEP
classically appears with superficial nonfollicular pustules on an erythematous background beginning in
intertriginous areas; it is characterized by intradermal,
subcorneal, and intracorneal pustules with frequent
spongiform changes on histopathology.1 In contrast,
TEN presents with a painful desquamative rash that
starts as dusky erythematous macules, generally
involving the mucosal membranes and covering
[30% of the body surface area. Histopathology shows
an interface dermatitis with keratinocyte necrosis,
which can progress to full-thickness epidermal necrolysis and separation from the dermis.2 Although classic
AGEP differs from TEN by clinical appearance and
histopathologic findings, cases with overlapping features have rarely been reported in the literature.3
Importantly, distinguishing severe AGEP from TEN is
essential due to differences in prognosis and management. We present a case series of AGEP with TEN-like
desquamation and highlight important clues in identifying severe and atypical cases of AGEP.

CASE SERIES
A chart review of 8 patients with extensive AGEP
was performed by 2 evaluators (K.M. and S.H.;
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Table I). Analysis of their clinical and histopathologic
findings highlights essential features that help in
correctly diagnosing AGEP (Figs 1-5; Supplemental
Figs 1 to 3 available via Mendeley at https://data.
mendeley.com/datasets/cgfm69xhnh/1). All cases
scored a minimum of 6, using the EuroSCAR criteria
for diagnosis of AGEP (Table II), with 2 cases
classified as ‘‘probable AGEP’’ and 6 cases classified
as ‘‘definite AGEP.’’4
All patients were seen as hospital dermatology
consults. Initial differential diagnoses included TEN,
AGEP, staphylococcal scalded skin syndrome, and/
or toxic shock syndrome. The data from Table I
show that all cases (n = 8) presented with widespread desquamation covering more than 50% of
the body surface area. Only 1 case (n = 1) presented with typical AGEP pustules on clinical
examination. Pain with desquamation was
observed in 1 patient (n = 1). Mucosal involvement
was seen in 1 patient (n = 1). Four patients (n = 4)
presented with a fever of [38 8C. All patients
presented with neutrophilia ([7000 neutrophils/
mm3). Antibiotics (b-lactams, n = 5; clindamycin,
n = 1; vancomycin, n = 1) and calcium channel
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Table I. Spectrum of clinical and histopathologic findings in 8 patients with severe acute generalized exanthematous pustulosis clinically mimicking toxic
epidermal necrolysis*
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Psoriasiform
hyperplasia
Parakeratosis
Papillary dermal
edema
Subepidermal cleft
Keratinocyte
necrosis
Dermal infiltrate

Extensive spongiosis
forming intraepidermal bullae with
exocytosis of N/E/L


Focal
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Spongiosis

AGEP, Acute generalized exanthematous pustulosis; E, eosinophils; L, lymphocytes; N, neutrophils; SSSS, staphylococcal scalded skin syndrome; TEN, toxic epidermal necrolysis; TSS, toxic shock
syndrome.
*EuroSCAR score interpretation: 0, no AGEP; 1 to 4, possible AGEP; 5 to 7, probable AGEP; 8 to 12, definite AGEP.
y
Classification of morphology defined by the EuroSCAR criteria is as follows: ‘‘Typical’’—typical morphology (many small, \5 mm, nonfollicular pustules on background edematous erythema,
predilection for intertriginous areas); ‘‘Compatible’’—not typical, but not strongly suggestive of other disease; and ‘‘Insufficient’’—lesions cannot be judged (due to late stage of lesions or poor
quality of images).
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Fig 1. A, Patient 3 presented with sheets of desquamation, flaccid bullae, and wet,
erythematous denuded skin. B, Punch biopsy showed extensive neutrophilic spongiosis
with necrotic keratinocytes. (B, Hematoxylin-eosin stain; original magnification: B, 340.)

Fig 2. A, Patient 5 presented with large sheets of superficial desquamation without identifiable
pustules. B, Punch biopsy showed mild spongiosis with neutrophilic exocytosis and intracorneal pustules. (B, Hematoxylin-eosin stain; original magnification: B, 3100.)

blockers (n = 1) comprised the suspected triggers.
The average time to onset of rash was 3.1 days,
and average time to resolution was 6.8 days.
Administered treatment included wound care and
topical steroids (n = 5), prednisone taper (n = 2),
and intravenous immunoglobulin (n = 1).
On histopathology, the classic AGEP finding
of subcorneal/intraepidermal pustules was
observed in most cases (n = 7). Other common
findings were spongiosis (n = 8), papillary
dermal edema (n = 8), and a superficial perivascular inflammatory infiltrate (n = 8). Features
overlapping with TEN, such as keratinocyte
necrosis (rare, n = 1; segmental, n = 4) and
dermal eosinophils (n = 3), were also observed.
Of the 5 frozen sections, 4 showed necrotic
keratinocytes (n = 4).

DISCUSSION
Correct identification of severe cases of AGEP can
be difficult due to a confluence of pustules leading to
large sheets of superficial desquamation. These cases
may be underreported and misdiagnosed as TEN
due to shared clinical and histopathologic features.
We present 8 cases of AGEP with TEN-like desquamation and an initial differential diagnosis that
included TEN. Cases were defined as AGEP by the
EuroSCAR criteria, a validation metric for the correct
diagnosis of AGEP. Cases are scored as ‘‘not,’’
‘‘possible,’’ ‘‘probable,’’ and ‘‘definite’’ AGEP.
Grading parameters include lesion morphology,
course of disease, and histopathologic features
(Table II).4 TEN-like AGEP has been reported in
the literature and its differentiation from actual TEN
is critical to avoiding overtreatment.3
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Table II. Features of acute generalized exanthematous pustulosis graded by EuroSCAR criteria4*
Features

Grading

Morphology
Pustules
Erythema
Distribution
Postpustular desquamation
Course
Mucosal involvement
Acute onset ( # 10 d)
Resolution ( # 15 d)
Fever ( $ 38 8C)
Neutrophilia ( $ 7000/mm3)
Histopathology
Other disease
Not representative/no histology
Exocytosis of neutrophils
Subcorneal and/or intraepidermal nonspongiform or NOS pustules
with papillary edema or subcorneal and/or intraepidermal spongiform or NOS pustules without papillary edema
Spongiform subcorneal and/or intraepidermal pustules with papillary
edema

Typicaly: 12; Compatiblez: 11; Insufficientx: 0
Typical: 12; Compatible: 11; Insufficient: 0
Typical: 12; Compatible: 11; Insufficient: 0
Yes: 11; No: 0
Yes:
Yes:
Yes:
Yes:
Yes:

2; No: 0
0; No: 2
0; No: 4
11; No: 0
11; No: 0
10
0
11
12
13

NOS, Not otherwise specified.
*Interpretation: # 0, no acute generalized exanthematous pustulosis (AGEP); 1 to 4, possible AGEP; 5 to 7, probable AGEP; 8 to 12, definite
AGEP.
y
Typical: Typical morphology with many nonfollicular sterile pustules arising on edematous erythema mainly in intertriginous areas.
z
Compatible: Not typical but not strongly suggestive of other disease.
x
Insufficient: Lesions cannot be judged (mostly because of late of the disease or poor quality of pictures).

Classically, AGEP is characterized by numerous
sterile, nonfollicular pustules on background erythema, but these are often missing when extensive
desquamation occurs. However, other features can
help clue the clinician into the diagnosis. Typically,
the desquamation in AGEP is more superficial than
that observed in TEN. However, clinical examination
cannot always reliably distinguish the level of split as
seen in cases 3 and 8. Histopathologic examination
for these 2 cases showed significant neutrophilic
spongiosis causing an intraepidermal sloughing a
few cells above the basal layer, explaining the
difficulty in clinical discrimination from the subepidermal split seen in TEN (Figs 1 and 5). Furthermore,
AGEP typically lacks the extensive mucous membrane involvement observed in TEN.4 Mucosal
involvement is seen in [90% of patients with TEN,
with a study showing 81% of patients with involvement of 2 or more mucous membranes.5 Our case
series included 1 patient with mucous membrane
involvement. Additionally, patients with AGEP are
less likely to have pain with desquamation compared
with patients with TEN. Only patient 7 responded
with pain upon palpation of her rash.
Per EuroSCAR criteria, laboratory values showing
peripheral neutrophilia ( $ 7000/mm3) and fever
( $ 38 8C) are features of classic AGEP, albeit they

are not specific for this particular drug reaction.1
Significant internal organ involvement is infrequent,
although lymphadenopathy and mild-to-moderate
aberrations in hepatic aminotransferases and creatinine clearance can be observed.4 In 1 retrospective
study, 10/58 AGEP patients developed at least 1 systemic involvement (hepatic, renal, or pulmonary).6
Both AGEP and TEN are commonly attributed to
drug reactions. AGEP has been associated with
aminopenicillins, pristinamycin, macrolides, quinolones, hydroxychloroquine, antifungal agents, and
diltiazem.7 TEN has been linked to an extensive
list of medications; most commonly allopurinol,
trimethoprim-sulfamethoxazole and other sulfonamide antibiotics, aminopenicillins, cephalosporins,
quinolones, phenobarbital, nonsteroidal antiinflammatory drugs, and anticonvulsants such as carbamazepine, lamotrigine, and phenytoin.2
The onset, progression, and prognosis help to
differentiate the 2 conditions. AGEP is more acute in
onset, as it typically occurs hours to days after
starting the drug, and TEN generally occurs 1 to
3 weeks after the inciting medication. Withdrawal of
the trigger drug leads to faster resolution in AGEP
(several days to 1 week) compared to that of TEN
(1-3 weeks or longer for extensive mucosal involvement).3 Our cases resolved in 6.8 days on average,
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Fig 3. A, Patient 6 presented with extensive erythematous macules that coalesced into large
patches with superficial desquamation. B, Punch biopsy showed spongiosis with subcorneal
pustules. (B, Hematoxylin-eosin stain; original magnification: B, 3100.)

Fig 4. A, Patient 7 presented with large areas of dry desquamation on the back and flaccid
bullae on the chest and extremities. B, Punch biopsy showed subcorneal pustules, significant
neutrophilic spongiosis, and necrotic keratinocytes. (B, Hematoxylin-eosin stain; original
magnification: B, 320.)

with all cases resolving before the 15-day cutoff used
by EuroSCAR criteria. The mortality rate is significantly higher in TEN, with TEN having an estimated
mortality of 30% or higher.8 Clinical comorbidities
are significant, including long-term ocular complications and persistent mucosal lesions. In contrast,
AGEP is generally self-limiting, and resolution of
lesions occurs within 1 to 2 weeks following drug
withdrawal.1,6 Mortality is less than 5% in AGEP with
few lasting comorbidities.1
AGEP has several histopathologic features,
including spongiform subcorneal or intraepidermal
pustules, a mixed perivascular and interstitial infiltrate 1/- eosinophils, papillary dermal edema, psoriasiform hyperplasia, and focal keratinocyte

necrosis. The clinical differential diagnosis includes
pustular psoriasis, subcorneal pustular dermatosis,
staphylococcal scalded skin syndrome, TEN, and
drug hypersensitivity syndrome. On histopathology,
pustular psoriasis may most commonly share features with AGEP. Histopathologic similarity with TEN
has also been reported.9
TEN is characterized by keratinocyte necrosis
with full-thickness epidermal necrolysis, a sparse
mixed inflammatory infiltrate, and subepidermal
bullae formation on histopathology.2 However,
epidermal necrosis and subepidermal bullae have
also been reported in AGEP.9 One study showed
scattered or segmental necrotic keratinocytes in 46%
and 7% of AGEP cases, respectively.10 Our case
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Fig 5. A, Patient 8 presented with bright red, raw-appearing erosions on the trunk and
extremities with dried, flaking skin and hemorrhagic crust on the head and neck. B, Punch
biopsy showed extensive neutrophilic spongiosis, papillary dermal edema, and necrotic
keratinocytes. (B, Hematoxylin-eosin stain; original magnification: B, 3100.)

series showed significant keratinocyte necrosis in 4
of the 8 patients. The higher proportion of cases with
segmental necrotic keratinocytes on histopathology
likely reflects the selection bias of clinically severe
AGEP cases.
In the case series, 4 of the 5 frozen sections
showed necrotic keratinocytes. Frozen section is a
valuable, yet underutilized tool for rapid inpatient
diagnosis of SCARs. It is especially useful in diagnosing Stevens-Johnson syndrome/TEN, with
epidermal necrosis being a characteristic feature.11
However, a singular focus on necrotic keratinocytes
can lead to a misdiagnosis of Stevens-Johnson syndrome/TEN in cases of severe AGEP where significant necrosis is possible. Frozen sections from
epidermis-only biopsies only further compound
this problem by providing partial sampling.
Consideration of EuroSCAR criteria such as clinical
onset/resolution of rash and lesion morphology can
help avoid this important diagnostic pitfall when
performing frozen sections for the rapid diagnosis of
SCARs; epidermal necrosis is not specific for TEN.
Although AGEP can present with features of TEN,
they are separate conditions with distinct etiologies.
AGEP occurs due to interleukin 8 (IL-8) recruitment
and activation of neutrophils as a type IVd T-cell
reaction, whereas TEN is a type IVc reaction, in
which cytotoxic CD81 T cells cause keratinocyte
apoptosis.12 Inflammatory skin reactions occur when
drug-specific T cells cause the release of granulysin
in TEN, and IL-8, interleukin 17, and interleukin 22 in
AGEP.13 Overlap between these immune reactions
may explain the presence of features of TEN in AGEP
cases.
Severe cases of AGEP may share clinical and
histopathologic features with TEN. However, in our

case series, superficial desquamation, the absence of
severe mucosal involvement, rapid onset/resolution
of rash, lack of pain with desquamation, and the
presence of neutrophilic spongiform pustules with
dermal edema on histopathology favored a diagnosis
of AGEP. Using EuroSCAR criteria can help narrow
the diagnosis, with all 8 cases scoring as ‘‘probable’’
or ‘‘definite’’ AGEP. Cases of AGEP with TEN-like
desquamation represent a distinct morphological
presentation of AGEP that should be recognized to
avoid misdiagnosis and mistreatment.
Conflicts of interest

None disclosed.
REFERENCES
1. De A, Das S, Sarda A, Pal D, Biswas P. Acute generalised
exanthematous pustulosis: an update. Indian J Dermatol. 2018;
63(1):22-29. https://doi.org/10.4103/ijd.IJD_581_17
2. Harr T, French LE. Toxic epidermal necrolysis and
Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5:39.
https://doi.org/10.1186/1750-1172-5-39
3. Copaescu AM, Bouffard D, Masse MS. Acute generalized
exanthematous pustulosis simulating toxic epidermal necrolysis: case presentation and literature review. Allergy Asthma
Clin Immunol. 2020;16:9. https://doi.org/10.1186/s13223020-0407-5
4. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute
generalized exanthematous pustulosis (AGEP)—a clinical reaction pattern. J Cutan Pathol. 2001;28(3):113-119. https:
//doi.org/10.1034/j.1600-0560.2001.028003113.x
5. Wetter DA, Camilleri MJ. Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year
period at Mayo Clinic. Mayo Clin Proc. 2010;85(2):131-138.
https://doi.org/10.4065/mcp.2009.0379
6. Hotz C, Valeyrie-Allanore L, Haddad C, et al. Systemic
involvement of acute generalized exanthematous pustulosis:
a retrospective study on 58 patients. Br J Dermatol. 2013;
169(6):1223-1232. https://doi.org/10.1111/bjd.12502
7. Feldmeyer L, Heidemeyer K, Yawalkar N. Acute generalized
exanthematous pustulosis: pathogenesis, genetic background,

122 Huang et al

clinical variants and therapy. Int J Mol Sci. 2016;17(8):1214.
https://doi.org/10.3390/ijms17081214
8. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J,
Wolkenstein P. SCORTEN: a severity-of-illness score for toxic
epidermal necrolysis. J Invest Dermatol. 2000;115(2):149-153.
https://doi.org/10.1046/j.1523-1747.2000.00061.x
9. Goh TK, Pang SM, Thirumoorthy T, Goh SGN. Acute generalised exanthematous pustulosis and toxic epidermal necrolysis
induced by carbamazepine. Singapore Med J. 2008;49(6):
507-510.
10. Halevy S, Kardaun SH, Davidovici B, Wechsler J, EuroSCAR,
RegiSCAR study group. The spectrum of histopathological
features in acute generalized exanthematous pustulosis: a

JAAD CASE REPORTS

SEPTEMBER 2021

study of 102 cases. Br J Dermatol. 2010;163(6):1245-1252.
https://doi.org/10.1111/j.1365-2133.2010.09967.x
11. Hosaka H, Ohtoshi S, Nakada T, Iijima M. Erythema multiforme,
Stevens-Johnson syndrome and toxic epidermal necrolysis:
frozen-section diagnosis. J Dermatol. 2010;37(5):407-412.
12. Peermohamed S, Haber RM. Acute generalized exanthematous
pustulosis simulating toxic epidermal necrolysis: a case report
and review of the literature. Arch Dermatol. 2011;147(6):697-701.
https://doi.org/10.1001/archdermatol.2011.147
13. Bouvresse S, Valeyrie-Allanore L, Ortonne N, et al. Toxic
epidermal necrolysis, DRESS, AGEP: do overlap cases exist?
Orphanet J Rare Dis 2012;7:72. https://doi.org/10.1186/
1750-1172-7-72

